The effect of various treatment modalities in idiopathic sudden sensorineural hearing loss: A retrospective evaluation

Main Article Content

Şeyda Belli

Abstract

Objective: In this study, we retrospectively evaluated the effects of treatment modalities on healing in patients diagnosed with idiopathic sudden sensorineural hearing loss.


Material and Method: In this study, we retrospectively reviewed the records of 65 patients diagnosed with idiopathic sudden sensorineural hearing loss and treated as inpatients. The treatment modalities applied to the patients were determined randomly. 


Results: The effect of intra-tympanic steroid and / or hyperbaric oxygen therapy in addition to intravenous steroid on 500, 1000, 2000 and 4000 Hz frequencies and improvement in bone conduction was not statistically significant.


Conclusion: Although intra-tympanic steroid or hyperbaric oxygen therapy in addition to intravenous steroid therapy, which is the standard treatment of idiopathic sudden sensorineural hearing loss, does not increase the rate of improvement and speed, it may help to reduce the undesirable effects of the steroid dose.

Downloads

Download data is not yet available.

Article Details

How to Cite
Belli, Şeyda. (2019). The effect of various treatment modalities in idiopathic sudden sensorineural hearing loss: A retrospective evaluation. Medical Science and Discovery, 6(12), 316-320. https://doi.org/10.36472/msd.v6i12.328
Section
Research Article

References

Levy E, Sela E, Letichevsky V, Ronen O. Nationwide Survey of Intratympanic Steroids for the Management of Sudden Sensorineural Hearing Loss. Isr Med Assoc. 2019 Feb;21(2):105-109. PMID: 30772961

Plontke SK, Bauer M, Meisner C. Comparison of pure tone audiometry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. Otol Neurotolog 2007; 28 (6): 753-63. DOI: 10.1097/mao.0b013e31811515ae PMID: 17948355

Stachler RJ, Chandrasekar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012; 146: S1. DOI: 10.1177/0194599812436449.

Blum A, Simsolo C. Acute unilateral sensorineural hearing loss due to H1N1 infection. IMAJ 2010; 12 (7): 450. PMID: 20862833

Merchant SN, Adams JC, Nadol JB Jr. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotolog 2005; 26 (2): 151-60. DOI: 10.1097/00129492-200503000-00004 PMID: 15793397


Ryan AF, Kujawa SG, Hammill T, Le Prell C, Kil J. Temporary and permanent noise-induced threshold shifts: a review of basic and clinical observations. Otol Neurotol. 2016;37(8):e271–e275. DOI: 10.1097/MAO.0000000000001071.

Spear SA, Schwart SR. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011; 145 (4): 534-43. DOI: 10.1177/0194599811419466.

Wei BP, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013 Jul 2;(7). CD003998. DOI:10.1002/ 14651852.CD003998.pub3

Bayoumy AB, de Ru JA. The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review. Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1859-1880. DOI: 10.1007/s00405-019-05469-7.

Kargın Kaytez S, Şafak MA, Demirci M. The effect of combined use of ıntratympanic steroid theraphy on sudden hearing loss. KBB ve BBC Dergisi 2019;27(2):51-6. DOI: 10.24179/kbbbbc.2019-65586

Kopke RD, Hoffer ME, Wester D, O’Leary MJ, Jackson RL. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol. 2001;22(4):475-9. DOI: 10.1097/00129492-200107000-00011 PMID: 11449103

Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22(1):18-23. DOI: 10.1097/00129492-200101000-00005 PMID: 11314710

Kiliç R, Safak MA, Oğuz H, Kargin S, Demirci M, Samim E, et al. Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol. 2007;28(3):312-6. DOI: 10.1097/MAO.0b013e31802fba7a PMID: 17414035

Haynes DS, O’Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117(1):3-15. DOI: 10.1097/01.mlg.0000245058.11866.15 PMID: 17202923

Tabuchi K, Nishimura B, Tanaka S, Hayashi K, Hirose Y, Hara A. Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species. Curr Neuropharmacol. 2010;8(2):128–134. DOI: 10.2174/157015910791233123.

Shi X. Physiopathology of the cochlear microcirculation. Hear Res. 2011;282(1–2):10–24. DOI: 10.1016/j.heares.2011.08.006.

Ruben RJ, Distenfeld A, Berg P, Carr R. Sudden sequential deafness as the presenting symptom of macroglobulinemia. JAMA. 1969;209(9):1364–1365. PMID: 4979452

Sone M, Mizuno T, Naganawa S, Nakashima T. Imaging analysis in cases with inflammation-induced sensorineural hearing loss. Acta Otolaryngol. 2009;129(3):239–243. DOI: 10.1080/00016480802226163 PMID: 18720058

Rudack C, Langer C, Stoll W, Rust S, Walter M. Vascular risk factors in sudden hearing loss. Thromb Haemost. 2006;95(3):454–461. DOI: 10.1160/TH05-08-0554 PMID: 16525573

Gussen R. Sudden deafness of vascular origin: a human temporal bone study. Ann Otol Rhinol Laryngol. 1976;85(1 Pt 1):94–100. DOI: 10.1177/000348947608500117 PMID: 1259320

Fisch U, Nagahara K, Pollak A. Sudden hearing loss: circulatory. Am J Otol. 1984;5(6):488–491. PMID: 6440439

Elwany S, Kamel T. Sensorineural hearing loss in sickle cell crisis. Laryngoscope. 1988;98(4):386–389. DOI:10.1288/00005537-198804000-00005 PMID: 3352436

Eryigit B, Ziylan F, Yaz F, Thomeer H. The effectiveness of hyperbaric oxygen in patients with idiopathic sudden sensorineural hearing loss: a systematic review. Eur Arch Oto-Rhino-Laryngol. 2018;275(12):2893–2904. DOI: 10.1007/s00405-018-5162-6.

Chen L, Zhang G, Zhang Z, Wang Y, Hu L, Wu J. Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: A systematic review and meta-analysis. Medicine (Baltimore). 2018 Sep;97(38):e12492. DOI: 10.1097/MD.0000000000012492. Review. PMID: 30235752

Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope. 2010;120(5):1011-21. DOI: 10.1002/lary.20873.

Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol. 1999;20(5):587-92. PMID: 10503580

Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol. 1980;106(12):772–776. DOI: 10.1001/archotol.1980.00790360050013 PMID: 7002129

Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope. 1984;94(5 Pt 1):664- 6. PMID: 6717224

Cole RR, Jahrsdoerfer RA. Sudden hearing loss: an update. Am J Otol. 1988;9(3):211-5. PMID: 3140670

d’Aldin C, Cherny L, Devriere F, Dancer A. Treatment of acoustic trauma. Ann N Y Acad Sci. 1999;884:328–344. DOI: 10.1111/j.1749-6632.1999.tb08652.x PMID: 10842604

Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Oto-Rhino-Laryngol. 2011;268(12):1735–1741. DOI: 10.1007/s00405-011-1563-5 PMID: 21431435

Capuano L, Cavaliere M, Parente G, Damiano A, Pezzuti G, Lopardo D, et al. Hyperbaric oxygen for idiopathic sudden hearing loss: is the routine application helpful? Acta Otolaryngol. 2015;135(7):692–697. DOI:10.3109/00016489.2015.1023355 PMID: 25813083

Bae SC, Noh HI, Jun BC, Jeon EJ, Seo JH, Park SY, et al. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Acta Otolaryngol. 2013;133(5):428-33. DOI: 10.3109/00016489.2012.749520 PMID: 23356871

Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone+high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29;(4):453-60.
DOI: 10.1097/MAO.0b013e318168da7a PMID: 18401285

Cho I, Lee HM, Choi SW, Kong SK, Lee IW, Goh EK, et al. Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Audiol Neuro-otol. 2018;23(4):199–207. DOI: 10.1159/000493558 PMID: 30380530